Vigil Neuroscience gains after early-stage data for Alzheimer’s drug (update)
Shares of Vigil Neuroscience (NASDAQ:VIGL) rose ~18% in the premarket on Thursday after the Sanofi (SNY)-backed biotech said that it expects to advance its Alzheimer's candidate VG-3927 into a Phase 2 ...
bovnews55m
Why Did HSBC Securities Give Intel Corp (INTC) Stock Hold Rating?
Intel Corp (INTC) stock saw a modest uptick, ending the day at $21.86 which represents a slight increase of $0.09 or 0.41% from the prior close of $21.77. The stock opened at $21.73 and touched a low ...